Biblio Discovery — Demo Discovery Service

26 results for "Jan Adolfsson"

Showing 1–20 · 1.31 seconds · RSS

  1. Journal Article

    Citing and endpoints

    Jan Adolfsson

    Scandinavian Journal of Urology, Vol. 56 No. 3 · 2022 · English · DOAJ Scopus

    No abstract available

  2. Journal Article

    Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsy

    Tobias Nordström; Jan Adolfsson; Henrik Grönberg et al.

    BMC Urology, Vol. 17 No. 1 · 2017 · English · DOAJ Scopus

    Abstract Background Multi-step testing might enhance performance of the prostate cancer diagnostic pipeline. Using PSA >1 ng/ml for first-line risk stratification and the Stockholm 3 Model (S3M) blood-test >10% risk of Gleason Score > 7 prostate cancer to inform biopsy decisions has been suggested…

  3. Journal Article

    Effects of pre-notification, invitation length, questionnaire length and reminder on participation rate: a quasi-randomised controlled trial

    Marie Koitsalu; Martin Eklund; Jan Adolfsson et al.

    BMC Medical Research Methodology, Vol. 18 No. 1 · 2018 · English · DOAJ Scopus

    Abstract Background Improving participation rates in epidemiologic studies using questionnaires and biological sampling is important for the generalizability of the outcome. The aim of this study was to examine the effects of pre-notification, invitation length, questionnaire length, and reminder…

  4. Journal Article Full text

    Quantifying the evidence for the risk of metabolic syndrome and its components following androgen deprivation therapy for prostate cancer: a meta-analysis.

    Cecilia Bosco; Danielle Crawley; Jan Adolfsson et al.

    PLoS ONE, Vol. 10 No. 3 · 2015 · English · DOAJ Scopus

    No meta-analysis is yet available for the risk of metabolic syndrome (MetS) following androgen deprivation therapy (ADT) for men with prostate cancer. To summarize the evidence for the link between ADT and MetS or its components quantitatively with a meta-analysis including all studies published to…

    Also available at: PLOS

  5. Journal Article Full text

    A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0

    Beth Russell; Hans Garmo; Kerri Beckmann et al.

    PLOS ONE, Vol. 13 No. 4 · 2018 · English · PLOS Scopus

    Objectives: To investigate the association between lower urinary-tract infections, their associated antibiotics and the subsequent risk of developing PCa. Subjects/Patients (or materials) and methods: Using data from the Swedish PCBaSe 3.0, we performed a matched case-control study (8762 cases and…

    Also available at: DOAJ

  6. Journal Article

    The STHLM3-model, Risk-based Prostate Cancer Testing Identifies Men at High Risk Without Inducing Negative Psychosocial Effects

    Marie Koitsalu; Martin Eklund; Jan Adolfsson et al.

    European Urology Open Science, Vol. 24 · 2021 · English · DOAJ Scopus

    Background: The new STHLM3 test, combining protein markers, genetic markers, and clinical data to assess a man’s prostate cancer (PCa) risk, has been investigated in Sweden within the frame of the STHLM3 trial. Objective: To assess whether the STHLM3 test influences men’s worry level, PCa…

  7. Journal Article Full text

    Predictors of participation in risk-based prostate cancer screening

    Marie Koitsalu; Martin Eklund; Jan Adolfsson et al.

    PLOS ONE, Vol. 13 No. 7 · 2018 · English · PLOS Scopus

    Background: Implementation of risk-based prostate cancer screening has been proposed as a means to reduce the harms of PSA screening. Little is known, however, about the factors influencing men’s decision to attend a prostate cancer screening based on a risk assessment. Method: We sent postal…

    Also available at: DOAJ

  8. Journal Article

    Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort study

    E. Lin; Hans Garmo; Mieke Van Hemelrijck et al.

    BMC Cancer, Vol. 21 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Background Gonadotropin Releasing Hormones agonists (GnRH), which are first line treatment for metastatic prostate cancer (PCa), increase risk of type 2 diabetes mellitus (T2DM). This study aims to quantify the association of use of GnRH with diabetes control in PCa men with T2DM. Methods…

  9. Journal Article

    Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study

    E. Lin; Hans Garmo; Mieke Van Hemelrijck et al.

    BMC Cancer, Vol. 20 No. 1 · 2020 · English · DOAJ Scopus

    Abstract Background Prostate cancer (PCa) and type 2 diabetes mellitus (T2DM) are prevalent conditions that often occur concomitantly. However, many aspects of the impact of T2DM, particularly the duration of T2DM and antidiabetic medications, on PCa risk are poorly understood. Methods To assess…

  10. Journal Article Full text

    Mortality following Hip Fracture in Men with Prostate Cancer

    Mieke Van Hemelrijck; Hans Garmo; Karl Michaëlsson et al.

    PLoS ONE, Vol. 8 No. 9 · 2013 · English · PLOS Scopus

    Background: Hip fractures are associated with increased mortality and are a known adverse effect of androgen deprivation therapy (ADT) for prostate cancer (PCa). It was our aim to evaluate how mortality after hip fracture is modified by PCa and ADT. Methods: PCa dataBase Sweden (PCBaSe 2.0) is…

    Also available at: DOAJ

  11. Journal Article Full text

    Consumption and direct costs of dental care for patients with head and neck cancer: A 16-year cohort study

    Duangjai Lexomboon; Pär Karlsson; Jan Adolfsson et al.

    PLOS ONE, Vol. 12 No. 8 · 2017 · English · PLOS Scopus

    Patients with head and neck (H&N) cancer are commonly treated with surgery and/or radiotherapy, which can increase the risk of oral infection, dental caries, and periodontal disease. The present study investigated dental care consumption and costs in patient with H&N cancer before and after the…

    Also available at: DOAJ

  12. Journal Article Full text

    Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in prostate cancer data base Sweden

    Gincy George; Hans Garmo; Sarah Rudman et al.

    Scandinavian Journal of Urology, Vol. 54 No. 1 · 2020 · English · DOAJ Scopus

    Abstract Aim: Gonadotropin-releasing hormone (GnRH) agonists are used to treat men with prostate cancer (PCa). To date, no study has fully assessed patterns of adherence to GnRH agonists. We investigated patterns of adherence to GnRH agonists using data from Prostate Cancer data Base Sweden…

    Also available at: DOAJ

  13. Journal Article

    Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data

    Eugenio Ventimiglia; Anna Bill-Axelson; Jan Adolfsson et al.

    European Urology Open Science, Vol. 44 · 2022 · English · DOAJ Scopus

    Background: Little is known about disease trajectories for men with castration-resistant prostate cancer (CRPC). Objective: To create a state transition model that estimates time spent in the CRPC state and its outcomes. Design, setting, and participants: The model was generated using…

  14. Journal Article

    Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort

    Yashar Khoshkar; Marcus Westerberg; Jan Adolfsson et al.

    BJUI Compass, Vol. 3 No. 2 · 2022 · English · DOAJ Scopus

    Abstract Objectives The objective of this study is to find clinical variables that predict the prognosis for men with castration‐resistant prostate cancer (CRPC) in a Swedish real‐life CRPC cohort, including a risk group classification to clarify the risk of succumbing to prostate cancer. This is a…